Neuroendocrine Carcinoma
Showing 51 - 75 of 8,789
Pancreatic Cancer Dietary Assessment Study
Completed
- Pancreatic Neoplasm
- +3 more
- Pancreo-KIT breath test
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Feb 1, 2022
SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)
Recruiting
- SCLC
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,
Not yet recruiting
- Prostate Carcinoma
- +3 more
- Bendamustine
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2023
Metastatic Large Cell Neuroendocrine Carcinoma, Metastatic Neuroendocrine Carcinoma, Metastatic Neuroendocrine Tumor Trial in
Active, not recruiting
- Metastatic Large Cell Neuroendocrine Carcinoma
- +3 more
- Cabozantinib S-malate
- +2 more
-
Birmingham, Alabama
- +46 more
Dec 30, 2022
Neuroendocrine Tumors - Patient Reported Outcomes
Enrolling by invitation
- Neuroendocrine Tumors
- +3 more
-
Gainesville, Florida
- +13 more
Jul 7, 2022
Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black
Not yet recruiting
- Gastroenteropancreatic Neuroendocrine Tumor
- Gastroenteropancreatic Neuroendocrine Neoplasm
- TQ Formula (black seed oil capsules)
- +2 more
-
Cleveland, OhioUniversity hospitals Seidman Cancer Center, Case Comprehensive C
Aug 12, 2022
Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)
Recruiting
- Neuroendocrine Tumours (NET)
- Neuroendocrine Carcinomas (NEC)
-
Santiago De Compostela, Galicia, Spain
- +4 more
Aug 1, 2022
Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)
Active, not recruiting
- Neuroendocrine Carcinoma
- Lu-DOTA-TATE
-
London, Ontario, CanadaLondon Health Sciences Centre
Apr 5, 2022
Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United
Recruiting
- Metastatic Lung Small Cell Carcinoma
- +16 more
- Elimusertib
- +2 more
-
Phoenix, Arizona
- +10 more
Mar 25, 2022
Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma
Recruiting
- Bladder Small Cell Neuroendocrine Carcinoma
- +16 more
- Carboplatin
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle
Active, not recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Large Cell Neuroendocrine Carcinoma of the Lung Trial in Germany (Atezolizumab)
Recruiting
- Large Cell Neuroendocrine Carcinoma of the Lung
-
Berlin, Germany
- +13 more
Jul 20, 2022
Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin
Completed
- Medullary Thyroid Carcinoma
- Nodular Goiter
- Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
-
Pilar, Buenos Aires, ArgentinaHospital Universitario Austral
Oct 5, 2023
Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic
Recruiting
- Hepatocarcinoma
- Pancreatic Tumor
- Hepatocellular carcinoma
- +2 more
-
Clichy, FranceHôpital Beaujon
Mar 20, 2023
DOTATOC PET/CT for Imaging NET Patients
Recruiting
- Neuroendocrine Tumors
- +15 more
- 68Ga-DOTATOC PET/CT
- 18F-FDG PET/CT
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 2, 2022
Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,
Not yet recruiting
- Carcinoid Tumor Lung
- +2 more
- 212-Lead Pentixather
- 203-Lead Pentixather SPECT/CT
-
Iowa City, IowaThe University of Iowa Theranostics Center
Sep 23, 2022
HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)
Recruiting
- HRD Cancer
- +2 more
- Berzosertib
- Sacituzumab Govitecan
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Gastrointestinal Stromal Tumors, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumor Trial in Changchun (Sunitinib malate
Completed
- Gastrointestinal Stromal Tumors
- +2 more
- Sunitinib malate capsules generic product
- Sunitinib malate capsules reference product
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Apr 6, 2023
Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,
Recruiting
- Advanced Solid Tumors
- +11 more
-
Boston, Massachusetts
- +4 more
Dec 12, 2022
Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston
Recruiting
- Lung Atypical Carcinoid Tumor
- +13 more
- Nivolumab
- Stereotactic Body Radiation Therapy
-
Conroe, Texas
- +2 more
Feb 25, 2022
Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)
Recruiting
- Pulmonary Neuroendocrine Neoplasm
- +9 more
-
Houston, TexasExcel Diagnostics and Nuclear Oncology Center
Jul 9, 2021
Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)
Recruiting
- Lung Small Cell Carcinoma
- +5 more
- Dostarlimab
- Niraparib
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2021
Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)
Recruiting
- Merkel Cell Carcinoma
- +5 more
- Avelumab
- Placebo
-
Port Macquarie, New South Wales, Australia
- +17 more
Aug 30, 2022